Literature DB >> 3607297

Full dose dipyridamole significantly improves thrombocytopenia in liver cirrhosis.

G Luzzatto, F Fabris, G De Franchis, G E Gerunda, A Girolami.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 3607297     DOI： 10.1007/bf00319646

Source DB:  PubMed          Journal:  Blut        ISSN： 0006-5242


× No keyword cloud information.
  6 in total

1.  Increased proportion of giant platelets and platelet distribution width are better indicators of altered platelet homeostasis than mean platelet volume in liver cirrhosis.

Authors:  G Luzzatto; G de Franchis; F Fabris; G E Gerunda; A Girolami
Journal:  Folia Haematol Int Mag Klin Morphol Blutforsch       Date:  1988

2.  Kinetics and in vivo distribution of 111-In-labelled autologous platelets in chronic hepatic disease: mechanisms of thrombocytopenia.

Authors:  K G Schmidt; J W Rasmussen; C Bekker; P E Madsen
Journal:  Scand J Haematol       Date:  1985-01

3.  Kinetic and functional studies of platelets, fibrinogen, and plasminogen in patients with hepatic cirrhosis.

Authors:  S F Stein; L A Harker
Journal:  J Lab Clin Med       Date:  1982-02

4.  The inverse relation between platelet volume and platelet number. Abnormalities in hematologic disease and evidence that platelet size does not correlate with platelet age.

Authors:  J Levin; J D Bessman
Journal:  J Lab Clin Med       Date:  1983-02

5.  Platelet-associated IgG in hepatitis and cirrhosis.

Authors:  D Graber; D Giuliani; C M Leevy; B S Morse
Journal:  J Clin Immunol       Date:  1984-03       Impact factor: 8.317

6.  Failure of two anti-platelet drugs (indobufen and dipyridamole) to improve thrombocytopenia in liver cirrhosis.

Authors:  G Luzzatto; F Fabris; G E Gerunda; F Zangrandi; A Girolami
Journal:  Acta Haematol       Date:  1987       Impact factor: 2.195
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.